CLDX · Celldex Therapeutics, Inc.

Track CLDX — free Ask ALVIS about CLDX

$37.59 +0.08 (+0.21%)

Market Cap

$2.94B

Shares

78.49M

Celldex Therapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Celldex Therapeutics, Inc. (CLDX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts

▼67% $236,000 '20 Q2 20-08-06 ▼91.2% $333,000 '21 Q4 22-02-28 LATEST ▲345.5% $695,000 −$53.80M '25 Q1 25-05-08

H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference

No reported result — non-financial event

Audio Transcript Slides

Celldex Therapeutics, Inc. Q1 FY2025 Earnings Call

Audio Transcript Slides 8-K10-Q

Celldex Therapeutics, Inc. Q4 FY2021 Earnings Call

Audio Transcript Slides 8-K10-K

Celldex Therapeutics, Inc. Q2 FY2020 Earnings Call

Audio Transcript Slides 8-K10-Q

Showing 1–4 of 4 earnings calls

Key facts CIK 744218 CUSIP 15117B202 13F (30d) 37 filings 37 filers Visit website Investor relations